TO FACILITATE EDUCATION, TRANSLATIONAL RESEARCH AND NOVEL APPROACHES TO THERAPY IN CLINICAL IMMUNOLOGY TO PROMOTE EXCELLENCE IN THE CARE OF PATIENTS WITH IMMUNOLOGIC/INFLAMMATORY DISORDERS.
Reported officers (all unpaid)
No paid executives reported in 2024. CLINICAL IMMUNOLOGY SOCIETY INC reported 7 unpaid officers and board members on its 990.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Revenue and expenses over time
CLINICAL IMMUNOLOGY SOCIETY INC reported revenue and expenses across 2 filing years.
What Diseases, Disorders & Medical Disciplines executives earn
CLINICAL IMMUNOLOGY SOCIETY INC reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $91,250.
These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 2,397 organizations across 2,397 filings (2021 – 2024).
See full Diseases, Disorders & Medical Disciplines compensation data →Common questions about CLINICAL IMMUNOLOGY SOCIETY INC
What are CLINICAL IMMUNOLOGY SOCIETY INC's revenue and expenses?
In 2024, CLINICAL IMMUNOLOGY SOCIETY INC reported $1.4M in total revenue and $1.5M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more